Abstract
Purpose
To report hepatic arterial-related complications encountered during planning and treatment angiograms for radioembolization and understand any potential-associated risk factors.
Materials and Methods
518 mapping or treatment angiograms for 180 patients with primary or metastatic disease to the liver treated by Yttrium-90 radioembolization between 2/2010 and 12/2015 were retrospectively reviewed. Intra-procedural complications were recorded per SIR guidelines. Patient demographics, indication for treatment, prior exposure to chemotherapeutic agents, operator experience, and disease burden were reviewed. Technical variables including type of radioembolic (glass vs. resin microspheres), indication for angiography (mapping vs. treatment), variant anatomy, and attempts at coil embolization were also assessed.
Results
Thirteen (13/518, 2.5%) arterial-related complications occurred in 13 patients. All but two complications resulted during transcatheter coil embolization to prevent non-target embolization. Complications included coil migration (n = 6), arterial dissection (n = 2), focal vessel perforation (n = 2), arterial thrombus (n = 2), and vasospasm prohibiting further arterial sub-selection (n = 1). Transarterial coiling was identified as a significant risk factor of complications on both univariate and multivariate regression analysis (odds ratio 7.8, P = 0.004). Usage of resin microspheres was also a significant risk factor (odds ratio 9.5, P = 0.042). No other technical parameters or pre-procedural variables were significant after adjusting for confounding on multivariate analysis (P > 0.05).
Conclusion
Intra-procedural hepatic arterial complications encountered during radioembolization were infrequent but occurred mainly during coil embolization to prevent non-target delivery to extra-hepatic arteries.
Similar content being viewed by others
References
Kennedy AS, McNeillie P, Dezarn WA, et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys. 2009;74:1494–500.
Lewandowski RJ, Memon K, Mulcahy MF, et al. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. Eur J Nucl Med Mol Imaging. 2014;41:1861–9.
Salem R, Lewandowski RJ, Kulik L, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011;140:497–507.
Riaz A, Lewandowski RJ, Kulik LM, et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol. 2009;20:1121–30.
Cosin O, Bilbao JI, Alvarez S, et al. Right gastric artery embolization prior to treatment with yttrium-90 microspheres. Cardiovasc Interv Radiol. 2007;30:98–103.
Maleux G, Wolter P, Vanslembrouck R, et al. Unexpected ischemic complication after proximal coil embolization of a replaced left hepatic artery before yttrium-90 radioembolization. J Vasc Interv Radiol. 2013;24:1745–7.
Brown DB. Hepatic artery dissection in a patient on bevacizumab resulting in pseudoaneurysm formation. Semin Interv Radiol. 2011;28:142–6.
Singh H, Cardella JF, Cole PE, et al. Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol. 2003;14:S283–8.
Wiggins E, Ibrahim SM, Lewandowski RJ, et al. Effect of chemotherapy on hepatic vasculature in patients undergoing Y-90 radioembolization for metastatic disease. Presented at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology. 19 Mar 2008.
Lewandowski RJ, Salem R. Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Semin Interv Radiol. 2006;23:64–72.
Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer. 2008;112:1538–46.
Murthy R, Eng C, Krishnan S, et al. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol. 2007;18:1588–91.
Fischman AM, Ward TJ, Patel RS, et al. Prospective, randomized study of coil embolization versus surefire infusion system during yttrium-90 radioembolization with resin microspheres. J Vasc Interv Radiol. 2014;25:1709–16.
Morshedi MM, Bauman M, Rose SC, et al. Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection. Cardiovasc Interv Radiol. 2015;38:381–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Bulent Arslan is a speaker and advisory board member for Penumbra®, Medtronic/Covidien®, and speaker for Cook®, W.L. Gore®, Guerbet®, and CR Bard®.
Rights and permissions
About this article
Cite this article
Ahmed, O., Patel, M.V., Masrani, A. et al. Assessing Intra-arterial Complications of Planning and Treatment Angiograms for Y-90 Radioembolization. Cardiovasc Intervent Radiol 40, 704–711 (2017). https://doi.org/10.1007/s00270-016-1555-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-016-1555-3